Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism

Ozderya A., Temizkan S., Gul A. E., Ozugur S., Cetin K., Aydin K.

ANNALS OF NUCLEAR MEDICINE, cilt.32, sa.4, ss.250-255, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s12149-018-1239-y
  • Dergi Adı: ANNALS OF NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.250-255
  • Anahtar Kelimeler: Tc-99m MIBI, Parathyroid adenoma, P-glycoprotein, Ki-67 ratio
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Hayır

Özet

Technetium 99 m methoxyisobutylisonitrile (Tc-99m MIBI) scintigraphy represents the most commonly utilized imaging modality for the detection of the diseased gland in patients with primary hyperparathyroidism (PHPT). In this study, we aimed to identify potential biological factors with an impact on MIBI sensitivity.